Phase I Pharmacokinetic Study (SALBLOCK)

Clinical trial NCT01564199 · COMPLETED

Trial details

NCT number: NCT01564199
Sponsor: Orion Corporation, Orion Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer Study

Start date: 2012-04-01
Primary completion: 2012-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.